Get the Stockscreener App
158.99
2.26%
-3.68
After Hours:
158.99
Repligen Corp stock is traded at $158.99, with a volume of 715.48K.
It is down -2.26% in the last 24 hours and down -5.32% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$162.67
Open:
$164.34
24h Volume:
715.48K
Relative Volume:
1.25
Market Cap:
$8.91B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
-512.87
EPS:
-0.31
Net Cash Flow:
$131.26M
1W Performance:
+8.22%
1M Performance:
-5.32%
6M Performance:
+3.95%
1Y Performance:
-18.09%
1-Day Range:
$156.18
$165.00
1-Week Range:
$143.83
$169.00
52-Week Range:
$113.50
$203.13
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
158.99 | 8.91B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Repligen (NASDAQ:RGEN) Shares Up 8.1% Following Strong Earnings - Defense World
Repligen's Q4 Earnings Beat Estimates, Revenues In Line - Nasdaq
The Analyst Verdict: Repligen In The Eyes Of 4 Experts - Benzinga
H.C. Wainwright maintains Buy on Repligen, target at $180 - Investing.com
Repligen Corporation (NASDAQ:RGEN) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord raises Repligen stock target to $170, maintains Hold - Investing.com
KeyBanc maintains Repligen stock with $220 target following Q4 results - Investing.com
Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Repligen: Q4 Earnings Snapshot - mySA
Repligen earnings beat by $0.03, revenue topped estimates - Investing.com
What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings - GuruFocus.com
Repligen stock target raised to $165 by Jefferies, retains hold - Investing.com
Repligen's Resurgence: Revolutionary Strides in Bioprocessing Signal Robust Growth Prospects - Elblog.pl
Repligen stock rises on positive Q4 results and 2025 outlook - Investing.com
Unlocking Bioprocessing Success: Repligen’s Market-Defying Momentum - Bit Perfect Solutions
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook - Benzinga
Repligen's Q4 Slightly Tops Expectations - The Motley Fool
Sabre, MicroStrategy, Repligen - TradingView
Earnings call transcript: Repligen Q4 2024 beats EPS forecast, stock surges - Investing.com
Repligen Corp Q4 Earnings: EPS of $0.44 Beats Estimates, Revenue Slightly Surpasses Expectations at $168 Million - GuruFocus.com
Repligen Q4 Profit Beats Estimates - Nasdaq
Repligen (RGEN) Beats Q4 Earnings Estimates - Nasdaq
Repligen Corporation Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
New York State Teachers Retirement System Has $7.76 Million Position in Repligen Co. (NASDAQ:RGEN) - Armenian Reporter
Van ECK Associates Corp Buys 3,066 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Global Hollow Fiber Filtration Market Growth, Demand Trends, - openPR
Legato Capital Management LLC Decreases Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Allspring Global Investments Holdings LLC Increases Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
WCM Investment Management LLC Sells 2,072 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen (NASDAQ:RGEN) Coverage Initiated at TD Cowen - MarketBeat
Mirae Asset Global Investments Co. Ltd. Raises Stock Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen (RGEN) to Release Earnings on Wednesday - MarketBeat
Repligen (RGEN) Shares Cross Below 200 DMA - Nasdaq
Hollow Fiber Filtration Market Growth, Demand Trends, Size & Competitive Analysis 2025-2032 | Repligen, Parker - EIN News
Repligen (RGEN) Sets Date for Critical Q4 Earnings ReleaseKey Details Inside - StockTitan
Repligen (NASDAQ:RGEN) Now Covered by Analysts at TD Cowen - Defense World
Repligen started at buy by TD Cowen, limited NIH exposure cited - MSN
Cowen initiates Repligen stock with Buy rating, $200 target - Investing.com
Cowen initiates Repligen stock with Buy rating, $200 target By Investing.com - Investing.com Canada
Stephens Investment Management Group LLC Acquires 37,057 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Receives $184.73 Average PT from Analysts - MarketBeat
Trust Point Inc. Decreases Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Conestoga Capital Advisors LLC Grows Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
SG Americas Securities LLC Has $496,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
KBC Group NV Trims Stake in Repligen Co. (NASDAQ:RGEN) - Defense World
Sivik Global Healthcare LLC Sells 15,000 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
SG Americas Securities LLC Decreases Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen (NASDAQ:RGEN) Shares Gap UpTime to Buy? - MarketBeat
Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains? - Yahoo Finance
HC Wainwright Cuts Repligen (NASDAQ:RGEN) Price Target to $180.00 - Defense World
Repligen's SWOT analysis: bioprocessing leader's stock faces growth challenges - Investing.com
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Repligen Corp Stock (RGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
Nov 21 '24 |
Option Exercise |
33.87 |
24,246 |
821,212 |
164,086 |
| Hunt Anthony | Director |
Nov 21 '24 |
Sale |
139.67 |
24,246 |
3,386,439 |
139,840 |
1.09%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):